Abstract

During the Phase I portion of this contract Singulex will develop Erenna assays for human EGFR, MMP?2, TIMP2, and MMp?2rr1MP-2 complex. We will carry out preliminary validation of these assays and demonstrate feasibility of these assays for measuring the target analytes in human tissues.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
261200900069C-0-0-1
Application #
7945131
Study Section
Project Start
2009-09-30
Project End
2010-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2009
Total Cost
$149,760
Indirect Cost

  Institution

Name
Singulex, Inc.
Department
Type
DUNS #
946338688
City
Alameda
State
CA
Country
United States
Zip Code
94502